CRUZ VERDE AMERICA
DEAD

Serial Number

87093891

Owner

Campo, Roger

Filing Date

Jul 6, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CRUZ VERDE AMERICA Trademark

Serial Number: 87093891

CRUZ VERDE AMERICA is a trademark filed by Campo, Roger on July 6, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Campo, Roger (3 trademarks)

12228 Venice Blvd., #386
Los Angeles, CA 90066

Entity Type: 99

Bediale-Campo, Luz

1772-J Avenida de Los Arboles, #190
Thousand Oaks, CA 91362

Entity Type: 01

Trademark Details

Filing Date

July 6, 2016

Registration Date

Not Registered

Goods & Services

Acetaminophen; Antacids; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antihistamines; Aspirin; Cough drops; Cough syrups; Cough expectorants; Decongestant capsules; Decongestant nasal sprays; Decongestants; Dietary food supplements; Eye drops; Laxatives; Oral analgesics; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents for epidermis; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Sleeping pills/tablets; Suppositories; Topical analgesic creams; Topical analgesics; Vitamin and mineral supplements; Alcohol for pharmaceutical purposes; Aloe vera preparations for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-cough drops; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Bee pollen for use as a dietary food supplement; Dermatological pharmaceutical products; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Digestives for pharmaceutical purposes; Ibuprofen for use as an oral analgesic; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Jalap; Menthol for pharmaceutical purposes; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 15, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 15, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 12, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2016 NWOS
NEW APPLICATION ENTERED
Jul 9, 2016 NWAP